1. Re-positive testing, clinical evolution and clearance of infection: results from COVID-19 cases in isolation in Viet Nam.
- Author
-
Hoang NA, Pham TQ, Quach HL, Nguyen KC, Colquhoun S, Lambert S, Luong DH, Tran QD, Phung DC, Duong TN, Ngu ND, Tran TA, Nguyen HBT, Dang DA, and Vogt F
- Subjects
- Hospitalization, Humans, Pandemics, SARS-CoV-2, Vietnam epidemiology, COVID-19 diagnosis, COVID-19 epidemiology
- Abstract
Objective: Asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and test re-positivity after a negative test have raised concerns about the ability to effectively control the coronavirus disease 2019 (COVID-19) pandemic. We aimed to investigate the prevalence of COVID-19 asymptomatic and pre-symptomatic infections during the second wave of COVID-19 in Viet Nam, and to better understand the duration of SARS-CoV-2 infection and the dynamics between the evolution of clinical symptoms and SARS-CoV-2 test positivity among confirmed COVID-19 cases., Methods: We conducted a cohort analysis on the first 50 confirmed cases during the second COVID-19 wave in Viet Nam using clinical, laboratory and epidemiological data collected from 9 March to 30 April 2020. Kaplan-Meier estimates were used to assess time to clearance of SARS-CoV-2 infection, and log-rank tests were used to explore factors related to time to SARS-CoV-2 infection clearance., Results: Most cases (58%) had no typical signs or symptoms of COVID-19 at the time of diagnosis. Ten cases (20%) were re-positive for SARS-CoV-2 during infection. Eight cases (16%) experienced COVID-19 symptoms after testing negative for SARS-CoV-2. The median duration from symptom onset until clearance of infection was 14 days (range: 6-31); it was longer in re-positive and older patients and those with pre-existing conditions., Conclusion: Asymptomatic and pre-symptomatic infections were common during the second wave of COVID-19 in Viet Nam. Re-positivity was frequent during hospitalization and led to a long duration of SARS-CoV-2 infection., ((c) 2021 The authors; licensee World Health Organization.)
- Published
- 2021
- Full Text
- View/download PDF